The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. “Saliva testing will help with the global shortage of swabs for sampling and increase testing […]
Recent Posts
- A Reflection on Microsoft’s MAI-DxO and the Future of AI in Dentistry and Medicine
- Blood Pressure Screening in Dental Practice: A Guide for Dentists
- Urine to Hydroxyapatite: A Sustainable Revolution in Maxillofacial and Implant Dentistry
- Risks of Over-Relying on AI for Doctors and Students
- Neurointegrative Dental Implants: A Transformative Advance in Restorative Dentistry
Archives